Komori
Shin-Etsu Chemical (4063) · TargetRestated

Pursuit of leading technology, quality and cost competitiveness in existing businesses and early commercialization of new fields

First written in FY2016. 16 of 18 entries say "Restated". Latest entry: FY2024.

18entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2022-Q1RestatedFY2023-Q2 – FY20242016: 120162017: 320172018: 320182019: 220192020: 220202021: 120212022: 220222023: 220232024: 22024
Same theme, other companies
Strengthening New Product and Technology Development Capabilities Through R&D and Basic ResearchA theme 218 companies write about · 0 as a headwind · 230 as a tailwind

47 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 230 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「The Group, comprising the company and its consolidated subsidiaries, has adopted as its basic R&D policy the strengthening of international competitiveness in research in existing business fields and the pursuit of leadership in technology, quality and cost, while pursuing proprietary technologies and early commercialization in new business fields. It conducts R&D in a planned, efficient and timely manner.」

    The company continues to pursue leadership in technology, quality and cost in existing businesses and early commercialization in new businesses as its R&D policy.
  2. FY2024-Q3RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the nine months ended December 31, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  3. FY2024-Q2RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the six months ended June 30, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  4. FY2023-Q3RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the nine months ended December 31, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  5. FY2023-Q2RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the six months ended June 30, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  6. FY2022ReframedAnnual report

    「The Group, comprising the company and its consolidated subsidiaries, has adopted as its basic R&D policy the strengthening of international competitiveness in research in existing business fields and the pursuit of leadership in technology, quality and cost, while pursuing proprietary technologies and early commercialization in new business fields. It conducts R&D in a planned, efficient and timely manner. In particular, in new fields, it is promoting R&D on energy-related products, semiconductor-related materials, optical and communications-related products, healthcare-related products, and materials and substances that contribute to the SDGs and carbon neutrality.」

    While maintaining its previous basic policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses, the company has explicitly added materials and substances that contribute to the SDGs and carbon neutrality to its new research fields.
  7. FY2022-Q1RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the three months ended March 31, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  8. FY2021-Q1RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the three months ended March 31, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  9. FY2020-Q3RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the nine months ended December 31, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  10. FY2020-Q2RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the six months ended June 30, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  11. FY2019-Q3RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the nine months ended December 31, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  12. FY2019-Q2RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the six months ended June 30, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  13. FY2018RestatedAnnual report

    「The Group, comprising the company and its consolidated subsidiaries, has adopted as its basic R&D policy the strengthening of international competitiveness in research in existing business fields and the pursuit of leadership in technology, quality and cost, while pursuing proprietary technologies and early commercialization in new business fields. It conducts R&D in a planned, efficient and timely manner.」

    The company continues to pursue leadership in technology, quality and cost in existing businesses and early commercialization in new businesses as its R&D policy.
  14. FY2018-Q3RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the nine months ended December 31, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  15. FY2018-Q2RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the six months ended June 30, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  16. FY2018-Q1RestatedAnnual report

    「There were no material changes in the status of the Group’s R&D activities during the three months ended March 31, XXXX.」

    The company states that there have been no material changes to its R&D policy of pursuing leadership in technology, quality and cost in existing businesses and early commercialization in new businesses.
  17. FY2017RestatedAnnual report

    「Our basic R&D policy is to strengthen international competitiveness in research in existing business fields and pursue leadership in technology, quality and cost, while pursuing proprietary technologies and early commercialization in new business fields. We conduct R&D in a planned, efficient and timely manner.」

    The company continues to pursue leadership in technology, quality and cost in existing businesses and early commercialization in new businesses as its R&D policy.
  18. FY2016First statedAnnual report

    「Our basic R&D policy is to strengthen international competitiveness in research in existing business fields and pursue leadership in technology, quality and cost, while pursuing proprietary technologies and early commercialization in new business fields. We conduct R&D in a planned, efficient and timely manner.」

    Different R&D targets have been established for existing and new businesses.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Shin-Etsu Chemical's next results are scheduled for 2026-10-27. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Pursuit of leading technology, quality and cost competitiveness in existing businesses and early commercialization of new fields | Shin-Etsu Chemical Co.,Ltd. (4063) | Komori